Provided by Tiger Fintech (Singapore) Pte. Ltd.

Invivyd, Inc.

1.76
-0.1300-6.88%
Post-market: 1.74-0.0200-1.14%19:48 EDT
Volume:8.28M
Turnover:14.95M
Market Cap:377.36M
PE:-1.91
High:2.01
Open:2.00
Low:1.70
Close:1.89
52wk High:2.74
52wk Low:0.3546
Shares:214.41M
Float Shares:132.00M
Volume Ratio:0.68
T/O Rate:6.28%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9194
EPS(LYR):-1.4333
ROE:-120.08%
ROA:-53.25%
PB:8.82
PE(LYR):-1.23

Loading ...

Invivyd Prices $50 Million Offering of Stock, Warrants

MT Newswires Live
·
Aug 21

BRIEF-Invivyd Prices Public Offering At $0.52 Per Share

Reuters
·
Aug 21

Invivyd Announces Pricing of $50 Million Public Offering of Common Stock and Pre-Funded Warrants

THOMSON REUTERS
·
Aug 21

Invivyd Inc - Prices Public Offering at $0.52 per Share

THOMSON REUTERS
·
Aug 21

BRIEF-Invivyd Announces Proposed Public Offering Of Common Stock

Reuters
·
Aug 21

Invivyd Inc. Announces Public Offering of Common Stock to Advance Clinical Programs and Research Initiatives

Reuters
·
Aug 21

Invivyd : Grants Underwriters Option for 30 Days to Purchase up to 15% of Co's Common Stock Sold in Public Offering

THOMSON REUTERS
·
Aug 21

Invivyd Inc - Cantor Acting as Sole Book-Running Manager for Invivyd Offering

THOMSON REUTERS
·
Aug 21

Press Release: Invivyd Announces Proposed Public Offering of Common Stock

Dow Jones
·
Aug 21

Chief Human Resources Officer Julie Green Reports Disposal of Common Shares of Invivyd Inc

Reuters
·
Aug 20

Jill Andersen, Chief Legal Officer, Reports Disposal of Invivyd Inc. Common Shares

Reuters
·
Aug 20

Chief Scientific Officer Robert D. Allen III Reports Disposal of Invivyd Inc. Common Shares

Reuters
·
Aug 20

Invivyd Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Aug 19

BRIEF-Invivyd Announces Continued Neutralizing Activity Of Pemgarda And VYD2311 Against Currently Dominant Sars-Cov-2 Variant XFG

Reuters
·
Aug 19

Invivyd Inc. Announces Positive In Vitro Data for PEMGARDA and VYD2311 Against Dominant COVID-19 Variant XFG

Reuters
·
Aug 19

Invivyd Announces Continued Neutralizing Activity of Pemgarda® (Pemivibart) and Vyd2311 Against Currently Dominant Sars-Cov-2 Variant Xfg (“Stratus”)

THOMSON REUTERS
·
Aug 19

Invivyd Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Aug 15

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Aug 15

Invivyd Q2 EPS $(0.12) Misses $(0.01) Estimate, Sales $11.79M Miss $23.16M Estimate

Benzinga
·
Aug 15

BRIEF-Invivyd Q2 EPS USD -0.12

Reuters
·
Aug 15